H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 87 Citations 25,729 246 World Ranking 476 National Ranking 286
Medicine D-index 98 Citations 30,956 353 World Ranking 4182 National Ranking 2367

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Gene
  • Immune system

Her primary scientific interests are in Atopic dermatitis, Immunology, Psoriasis, Immune system and Internal medicine. Her Atopic dermatitis research incorporates elements of FOXP3, SCORAD and Pathology. As part of her studies on Immunology, she often connects relevant subjects like Disease.

The concepts of her Disease study are interwoven with issues in Phenotype and Dendritic cell. She has included themes like Tumor necrosis factor alpha, Inflammation, Thymic stromal lymphopoietin, Cytokine and CCL17 in her Psoriasis study. Her studies deal with areas such as Gastroenterology and Placebo as well as Internal medicine.

Her most cited work include:

  • Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis (748 citations)
  • Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. (739 citations)
  • Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. (595 citations)

What are the main themes of her work throughout her whole career to date?

Emma Guttman-Yassky mostly deals with Atopic dermatitis, Immunology, Dermatology, Immune system and Psoriasis. Her Atopic dermatitis study integrates concerns from other disciplines, such as Internal medicine, Disease and SCORAD. Her Internal medicine research includes elements of Gastroenterology and Placebo.

Filaggrin, Inflammation, T cell, Immunoglobulin E and Cytokine are the subjects of her Immunology studies. The various areas that she examines in her Immune system study include Allergic contact dermatitis and Pathology. Her Psoriasis study combines topics from a wide range of disciplines, such as Tumor necrosis factor alpha, Transcriptome and Interleukin 17.

She most often published in these fields:

  • Atopic dermatitis (106.40%)
  • Immunology (79.06%)
  • Dermatology (35.96%)

What were the highlights of her more recent work (between 2019-2021)?

  • Atopic dermatitis (106.40%)
  • Immunology (79.06%)
  • Dupilumab (16.50%)

In recent papers she was focusing on the following fields of study:

Emma Guttman-Yassky spends much of her time researching Atopic dermatitis, Immunology, Dupilumab, Internal medicine and Immune system. Emma Guttman-Yassky has researched Atopic dermatitis in several fields, including Placebo, Disease and SCORAD. Her study explores the link between Immunology and topics such as Phenotype that cross with problems in Loricrin and Keratin 16.

Her Dupilumab research includes elements of Tralokinumab, Clinical trial, Comorbidity and Intensive care medicine. Her biological study spans a wide range of topics, including Gastroenterology, Alopecia areata and Placebo-controlled study. Her Immune system research incorporates elements of Psoriasis, Pathology, Skin biopsy, Biomarker and Epidermal barrier.

Between 2019 and 2021, her most popular works were:

  • Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial. (72 citations)
  • Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial. (72 citations)
  • Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial (58 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Immune system

Her primary scientific interests are in Atopic dermatitis, Immunology, Dupilumab, Eczema Area and Severity Index and Immune system. Her Atopic dermatitis research is under the purview of Dermatology. In her work, Loading dose is strongly intertwined with Lebrikizumab, which is a subfield of Dupilumab.

Her Eczema Area and Severity Index research incorporates themes from Real-time polymerase chain reaction and CCL18. Her Immune system research integrates issues from Skin biopsy, Psoriasis, Tolerability and Body surface area. Emma Guttman-Yassky focuses mostly in the field of Psoriasis, narrowing it down to matters related to Pathophysiology and, in some cases, Biomarker.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.

Lisa A. Beck;Diamant Thaçi;Jennifer D. Hamilton;Neil M. Graham.
The New England Journal of Medicine (2014)

975 Citations

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Eric L. Simpson;Thomas Bieber;Emma Guttman-Yassky;Lisa A. Beck.
The New England Journal of Medicine (2016)

940 Citations

Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.

K.E. Nograles;L.C. Zaba;E. Guttman-Yassky;J. Fuentes-Duculan.
British Journal of Dermatology (2008)

776 Citations

IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells

Kristine E. Nograles;Lisa C. Zaba;Avner Shemer;Judilyn Fuentes-Duculan.
The Journal of Allergy and Clinical Immunology (2009)

649 Citations

Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.

Julia K. Gittler;Julia K. Gittler;Avner Shemer;Mayte Suárez-Fariñas;Judilyn Fuentes-Duculan.
The Journal of Allergy and Clinical Immunology (2012)

615 Citations

Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis

Andrea Chiricozzi;Emma Guttman-Yassky;Emma Guttman-Yassky;Mayte Suárez-Fariñas;Kristine E. Nograles.
Journal of Investigative Dermatology (2011)

490 Citations

Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis

Emma Guttman-Yassky;Michelle A. Lowes;Judilyn Fuentes-Duculan;Lisa C. Zaba.
Journal of Immunology (2008)

369 Citations

Deciphering the Complexities of Atopic Dermatitis: Shifting Paradigms in Treatment Approaches

Donald Y.M. Leung;Emma Guttman-Yassky.
The Journal of Allergy and Clinical Immunology (2014)

367 Citations

Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

Thomas Werfel;Jean-Pierre Allam;Tilo Biedermann;Kilian Eyerich.
The Journal of Allergy and Clinical Immunology (2016)

360 Citations

Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities.

Mayte Suárez-Fariñas;Suzanne J. Tintle;Avner Shemer;Andrea Chiricozzi;Andrea Chiricozzi.
The Journal of Allergy and Clinical Immunology (2011)

329 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Emma Guttman-Yassky

Kenji Kabashima

Kenji Kabashima

Kyoto University

Publications: 135

James G. Krueger

James G. Krueger

Rockefeller University

Publications: 91

Thomas Werfel

Thomas Werfel

Hannover Medical School

Publications: 63

Jacob P. Thyssen

Jacob P. Thyssen

University of Copenhagen

Publications: 60

Donald Y.M. Leung

Donald Y.M. Leung

National Jewish Health

Publications: 53

Alan D. Irvine

Alan D. Irvine

Trinity College Dublin

Publications: 49

Mayte Suárez-Fariñas

Mayte Suárez-Fariñas

Icahn School of Medicine at Mount Sinai

Publications: 49

Cezmi A. Akdis

Cezmi A. Akdis

University of Zurich

Publications: 46

Tilo Biedermann

Tilo Biedermann

Technical University of Munich

Publications: 41

Stephan Weidinger

Stephan Weidinger

Kiel University

Publications: 36

Lisa A. Beck

Lisa A. Beck

University of Rochester Medical Center

Publications: 35

Lawrence F. Eichenfield

Lawrence F. Eichenfield

University of California, San Diego

Publications: 34

Gil Yosipovitch

Gil Yosipovitch

University of Miami

Publications: 33

Neil M.H. Graham

Neil M.H. Graham

Regeneron (United States)

Publications: 33

James T. Elder

James T. Elder

University of Michigan–Ann Arbor

Publications: 33

Thomas Bieber

Thomas Bieber

University of Bonn

Publications: 30

Something went wrong. Please try again later.